Bionano Genomics (BNGO) Leases (2021 - 2025)
Historic Leases for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $3.5 million.
- Bionano Genomics' Leases rose 435.69% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 435.69%. This contributed to the annual value of $3.3 million for FY2024, which is 4143.44% down from last year.
- As of Q3 2025, Bionano Genomics' Leases stood at $3.5 million, which was up 435.69% from $3.8 million recorded in Q2 2025.
- Over the past 5 years, Bionano Genomics' Leases peaked at $7.2 million during Q4 2022, and registered a low of $3.2 million during Q1 2025.
- For the 5-year period, Bionano Genomics' Leases averaged around $5.3 million, with its median value being $5.8 million (2022).
- As far as peak fluctuations go, Bionano Genomics' Leases surged by 793.6% in 2022, and later crashed by 4568.88% in 2024.
- Bionano Genomics' Leases (Quarter) stood at $6.7 million in 2021, then grew by 7.94% to $7.2 million in 2022, then dropped by 22.0% to $5.6 million in 2023, then plummeted by 41.43% to $3.3 million in 2024, then increased by 6.0% to $3.5 million in 2025.
- Its Leases stands at $3.5 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.2 million for Q1 2025.